1992
Why "conventional" researchers think the way they doSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Robert Nielsen
International AIDS Conference VIII: HIV Progression and Markers of HIV InfectionSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
VIII International Conference on AIDS: Pneumocystis carinii pneumoniaSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Mari Kitahata, M.D.
International AIDS Conference VIII: Protease inhibitors.Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
International AIDS Conference VIII: Non-Reverse Transcriptase InhibitorsSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
International AIDS Conference VIII: Reverse Transcriptase InhibitorsSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
Dapsone-Pyrimethamine for the Treatment of Toxoplasma Encephalitis: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Chronic vs. Intermittent Therapy for Toxoplasma Encephalitis: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Therapy for Toxoplasma Encephalitis: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Value of MR Imaging of the Brain as a "Screening" Tool in Asymptomatic HIV-seropositive Persons: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Treatments for Peripheral Neuropathy: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Calcium Channel Blockers Protect Rat Brain Cells in Culture from Effects of gp120: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Early Detection of AIDS Dementia in Children: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Risk Factors for Developing ADC: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
Promising Treatment for AIDS Dementia Complex: Highlights of Neurological Research from the VIII International Conference on AIDS, Amsterdam, July 19-24, 1992Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lyn Frumkin, M.D., Ph.D.
VIII International Conference on AIDS: Natural History of HIV InfectionSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
International AIDS Conference VIII: Multiple Opportunistic Pathogen Prophylactic Strategies (MOPPS)Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
VIII International Conference on AIDS: Mycobacterium Avium Complex (MAC)Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
VIII International Conference on AIDS: Multidrug-resistant Tuberculosis (MDRTB)Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
VIII International Conference on AIDS: MalignanciesSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
ACTU Study for Herpes, Needs Your AssistanceSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Tim Schacker, M.D.
VIII International Conference on AIDS: Therapeutic HIV VaccinesSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Mari Kitahata, M.D.
VIII International Conference on AIDS: Women and HIVSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Mari Kitahata, M.D.
VIII International Conference on AIDS: Cytomegalovirus (CMV), and Herpesvirus (HSV)Seattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Lori Panther, M.D.
AZT Resistance in HIV InfectionSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Winston Cavert, MD
VIII International Conference on AIDS: Antiretroviral TherapySeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Mari Kitahata, M.D.
Venous Access - Specific types, advantages and disadvantagesSeattle Treatment Education Project: STEP Perspective - Volume 4, Number 3 - October 1992Dyer Downing, R.N.
This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1998. AEGIS.